241 related articles for article (PubMed ID: 28624610)
1. Anti-FcγRIIB mAb suppresses murine IgG-dependent anaphylaxis by Fc domain targeting of FcγRIII.
Clay CD; Strait RT; Mahler A; Khodoun MV; Finkelman FD
J Allergy Clin Immunol; 2018 Apr; 141(4):1373-1381.e5. PubMed ID: 28624610
[TBL] [Abstract][Full Text] [Related]
2. Rapid desensitization of mice with anti-FcγRIIb/FcγRIII mAb safely prevents IgG-mediated anaphylaxis.
Khodoun MV; Kucuk ZY; Strait RT; Krishnamurthy D; Janek K; Clay CD; Morris SC; Finkelman FD
J Allergy Clin Immunol; 2013 Dec; 132(6):1375-87. PubMed ID: 24139828
[TBL] [Abstract][Full Text] [Related]
3. IgG subclasses determine pathways of anaphylaxis in mice.
Beutier H; Gillis CM; Iannascoli B; Godon O; England P; Sibilano R; Reber LL; Galli SJ; Cragg MS; Van Rooijen N; Mancardi DA; Bruhns P; Jönsson F
J Allergy Clin Immunol; 2017 Jan; 139(1):269-280.e7. PubMed ID: 27246523
[TBL] [Abstract][Full Text] [Related]
4. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
[TBL] [Abstract][Full Text] [Related]
5. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG.
Ujike A; Ishikawa Y; Ono M; Yuasa T; Yoshino T; Fukumoto M; Ravetch JV; Takai T
J Exp Med; 1999 May; 189(10):1573-9. PubMed ID: 10330436
[TBL] [Abstract][Full Text] [Related]
6. Lyn is essential for fcgamma receptor III-mediated systemic anaphylaxis but not for the Arthus reaction.
Yuasa T; Ono M; Watanabe T; Takai T
J Exp Med; 2001 Mar; 193(5):563-72. PubMed ID: 11238587
[TBL] [Abstract][Full Text] [Related]
7. Suppression of IgE-mediated anaphylaxis and food allergy with monovalent anti-FcεRIα mAbs.
Khodoun MV; Morris SC; Shao WH; Potter C; Angerman E; Kiselev A; Yarawsky AE; Herr AB; Klausz K; Otte A; Peipp M; Finkelman FD
J Allergy Clin Immunol; 2021 May; 147(5):1838-1854.e4. PubMed ID: 33326804
[TBL] [Abstract][Full Text] [Related]
8. Galactosylation of IgG1 modulates FcγRIIB-mediated inhibition of murine autoimmune hemolytic anemia.
Yamada K; Ito K; Furukawa J; Nakata J; Alvarez M; Verbeek JS; Shinohara Y; Izui S
J Autoimmun; 2013 Dec; 47():104-10. PubMed ID: 24055197
[TBL] [Abstract][Full Text] [Related]
9. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking.
Strait RT; Morris SC; Finkelman FD
J Clin Invest; 2006 Mar; 116(3):833-41. PubMed ID: 16498503
[TBL] [Abstract][Full Text] [Related]
10. Pathways of anaphylaxis in the mouse.
Strait RT; Morris SC; Yang M; Qu XW; Finkelman FD
J Allergy Clin Immunol; 2002 Apr; 109(4):658-68. PubMed ID: 11941316
[TBL] [Abstract][Full Text] [Related]
11. Anti-IL-4 antibody inhibits antigen specific IgE response but fails to prevent chicken gamma globulin-induced active systemic anaphylaxis: evidence for the involvement of IgG antibodies.
Lee HK; Lee HH; Park YM; Park HJ; Lee JH; Ha TY
J Korean Med Sci; 1996 Apr; 11(2):111-7. PubMed ID: 8835757
[TBL] [Abstract][Full Text] [Related]
12. IgG-mediated anaphylaxis via Fc gamma receptor in CD40-deficient mice.
Wakayama H; Hasegawa Y; Kawabe T; Saito H; Kikutani H; Shimokata K
Clin Exp Immunol; 1998 Nov; 114(2):154-60. PubMed ID: 9822270
[TBL] [Abstract][Full Text] [Related]
13. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis.
Miyajima I; Dombrowicz D; Martin TR; Ravetch JV; Kinet JP; Galli SJ
J Clin Invest; 1997 Mar; 99(5):901-14. PubMed ID: 9062348
[TBL] [Abstract][Full Text] [Related]
14. Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.
Burton OT; Logsdon SL; Zhou JS; Medina-Tamayo J; Abdel-Gadir A; Noval Rivas M; Koleoglou KJ; Chatila TA; Schneider LC; Rachid R; Umetsu DT; Oettgen HC
J Allergy Clin Immunol; 2014 Dec; 134(6):1310-1317.e6. PubMed ID: 25042981
[TBL] [Abstract][Full Text] [Related]
15. Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB.
Nandakumar KS; Andrén M; Martinsson P; Bajtner E; Hellström S; Holmdahl R; Kleinau S
Eur J Immunol; 2003 Aug; 33(8):2269-77. PubMed ID: 12884302
[TBL] [Abstract][Full Text] [Related]
16. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
Hamaguchi Y; Xiu Y; Komura K; Nimmerjahn F; Tedder TF
J Exp Med; 2006 Mar; 203(3):743-53. PubMed ID: 16520392
[TBL] [Abstract][Full Text] [Related]
17. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
[TBL] [Abstract][Full Text] [Related]
18. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
[TBL] [Abstract][Full Text] [Related]
19. Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis.
Khodoun MV; Strait R; Armstrong L; Yanase N; Finkelman FD
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12413-8. PubMed ID: 21746933
[TBL] [Abstract][Full Text] [Related]
20. IgG:FcγRIIb signals block effector programs of IgE:FcεRI-activated mast cells but spare survival pathways.
Kanagaratham C; Derakhshan T; El Ansari YS; Furiness KN; Hollers E; Keldsen M; Oettgen HC; Dwyer DF
J Allergy Clin Immunol; 2023 Aug; 152(2):453-468. PubMed ID: 37030590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
